Pcv2 mycoplasma hyopneumoniae immunogenic compositions and...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/295 (2006.01) A61K 39/04 (2006.01) A61P 31/04 (2006.01) A61P 37/04 (2006.01) G01N 33/564 (2006.01)

Patent

CA 2712006

Multivalent combination vaccines are provided which include an immunological agent effective for reducing the incidence of or lessening the severity of M. hyo infection, preferably M. hyo bacterin, or an immunogenic composition comprising M. hyo bacterin, and at least one immunogenic active component of another disease-causing organism in swine, preferably PCV2 wherein the preferred PCV2 antigen for such a multivalent vaccine is PCV2 ORF 2 protein.

La présente invention concerne des vaccins de combinaison multivalents. Lesdits vaccins incluent un agent immunologique efficace dans la réduction de lincidence, ou dans la diminution de la gravité, dune infection par M. hyo, de préférence par la bactérine M. hyo, ou une composition immunogène comprenant la bactérine M. hyo, et au moins un composant actif immunogène dun autre organisme pathogène chez le porc, de préférence PCV2. Lantigène PCV2 préféré pour un tel vaccin multivalent est la protéine PCV2 ORF 2.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pcv2 mycoplasma hyopneumoniae immunogenic compositions and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pcv2 mycoplasma hyopneumoniae immunogenic compositions and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pcv2 mycoplasma hyopneumoniae immunogenic compositions and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1549055

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.